| Application no. and date | 19749938.7 (espacenet) (Federated) (European Patent Register), 20190722 | | Patent/reg. no. and date | DK/EP 3826662, 20240911 | | Publication date | 20210602 | | Priority no. and date | US 201862702180 P, 20180723, US 201862730562 P, 20180913, US 201862740640 P, 20181003 | | EP pub. no. and date |
EP 3826662 20210602 | | Effective date | | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | V480644DK00 | | Inventor | ALSINA-FERNANDEZ, Jorge, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
COSKUN, Tamer, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
CABRERA, Over, c/o ELI LILLY AND COMPANY P.O. Box 6288
Indianapolis, Indiana 46206-6288, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61P 3/10 (2006.01) | | Title | Fremgangsmåde til anvendelse af en GIP/GLP1-co-agonist til diabetes | | Int. application no. | US2019042824 | | Int. publication no. | WO2020023388 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
